Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

1 Jan 2001

Abstract excerpt

Kallikrein gene 5 (KLK5, also known as KLK-L2), located on chromosome 19q13.4, is one of the newly identified members of the kallikrein gene family, which is a subgroup of the serine protease enzyme family. In normal human tissues, KLK5 is highly expressed in skin, mammary gland and testis. Preliminary RT-PCR analysis has indicated that KLK5 is expressed in a subset of ovarian tumours. We have thus hypothesized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Cell Adhesion Molecules Research
Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11237385
DOI: 10.1054/bjoc.2000.1649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerPMID 11237385Read ↗

Down‐regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesSemantic proximity Read ↗

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancerSemantic proximity Read ↗

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.Semantic proximity Read ↗

KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancerSemantic proximity Read ↗

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.Semantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.Semantic proximity Read ↗

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencingSemantic proximity Read ↗

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspectsSemantic proximity Read ↗

Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevanceSemantic proximity Read ↗

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.Semantic proximity Read ↗

Human tissue kallikreins and testicular cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.